Sign In
Buy TTOO
$0.0020
+0 (+0%)
At Close: Jun 03, 2026
Financial Analysis: Biostage (OTCMKTS:BSTG) and T2 Biosystems (NASDAQ:TTOO)
01:35am, Sunday, 05'th Apr 2026
T2 Biosystems (NASDAQ: TTOO - Get Free Report) and Biostage (OTCMKTS:BSTG - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two business
Reviewing T2 Biosystems (NASDAQ:TTOO) & Acutus Medical (NASDAQ:AFIB)
01:38am, Thursday, 19'th Feb 2026
Risk and Volatility Acutus Medical has a beta of -1.28, meaning that its stock price is 228% less volatile than the S&P 500. Comparatively, T2 Biosystems has a beta of 0.88, meaning that its stock pri
T2 Biosystems (NASDAQ:TTOO) Shares Cross Below Two Hundred Day Moving Average – Should You Sell?
03:12am, Saturday, 24'th Jan 2026
T2 Biosystems, Inc. (NASDAQ: TTOO - Get Free Report) passed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $0.02 and traded as low
T2 Biosystems (NASDAQ:TTOO) versus Minerva Surgical (NASDAQ:UTRS) Head-To-Head Review
02:22am, Saturday, 10'th Jan 2026
Valuation and Earnings This table compares Minerva Surgical and T2 Biosystems"s revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Ear
T2 Biosystems (NASDAQ:TTOO) Stock Price Passes Above 50 Day Moving Average – Here’s What Happened
04:20am, Saturday, 27'th Dec 2025
Shares of T2 Biosystems, Inc. (NASDAQ: TTOO - Get Free Report) passed above its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $0.01 and traded as high
T2 Biosystems (NASDAQ:TTOO) Shares Cross Above 50 Day Moving Average – What’s Next?
04:33am, Wednesday, 03'rd Dec 2025
T2 Biosystems, Inc. (NASDAQ: TTOO - Get Free Report)'s share price crossed above its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of $0.01 and traded as high
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
09:00am, Monday, 16'th Dec 2024
LEXINGTON, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced th
Intends to accelerate broad adoption of direct-from-whole-blood diagnostics, generate non-dilutive capital, and create a new royalty revenue stream Intends to accelerate broad adoption of direct-from-
T2 Biosystems, Inc. (TTOO) Q3 2024 Earnings Call Transcript
06:12pm, Thursday, 14'th Nov 2024
T2 Biosystems, Inc. (NASDAQ:TTOO ) Q3 2024 Earnings Conference Call November 14, 2024 4:30 PM ET Company Participants Trip Taylor - Investor Relations John Sperzel - Chairman & Chief Executive Officer
T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024
08:00am, Tuesday, 05'th Nov 2024
LEXINGTON, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today tha
T2 Biosystems, Inc. (TTOO) Business Update Conference Call Transcript
08:27pm, Thursday, 10'th Oct 2024
T2 Biosystems, Inc. (NASDAQ:TTOO ) Business Update Conference Call October 10, 2024 4:30 PM ET Company Participants Trip Taylor - IR John Sperzel - Chairman and CEO Conference Call Participants Eduard
T2 Biosystems to Host Business Update Call on October 10, 2024
04:05pm, Tuesday, 08'th Oct 2024
LEXINGTON, Mass., Oct. 08, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today tha
LEXINGTON, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,
T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union
09:00am, Friday, 20'th Sep 2024
LEXINGTON, Mass., Sept. 20, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,
T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
04:05pm, Tuesday, 27'th Aug 2024
LEXINGTON, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced pla
